Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C29H34N4O3S |
Molecular Weight | 518.67 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(O)C(C)=C2CC[C@](C)(OC2=C1C)C(=O)N3CCN(CC3)C4=CC=C(NC(=N)C5=CC=CS5)C=C4
InChI
InChIKey=STCYUKSGPHEXDI-LJAQVGFWSA-N
InChI=1S/C29H34N4O3S/c1-18-19(2)26-23(20(3)25(18)34)11-12-29(4,36-26)28(35)33-15-13-32(14-16-33)22-9-7-21(8-10-22)31-27(30)24-6-5-17-37-24/h5-10,17,34H,11-16H2,1-4H3,(H2,30,31)/t29-/m0/s1
Molecular Formula | C29H34N4O3S |
Molecular Weight | 518.67 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Neuroprotective effects of (S)-N-[4-[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)carbonyl]-1-piperazinyl]phenyl]-2-thiophenecarboximid-amide (BN 80933), an inhibitor of neuronal nitric-oxide synthase and an antioxidant, in model of transient focal cerebral ischemia in mice. | 2003 Aug |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:35:29 GMT 2023
by
admin
on
Sat Dec 16 08:35:29 GMT 2023
|
Record UNII |
98L2F93VSI
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
98L2F93VSI
Created by
admin on Sat Dec 16 08:35:29 GMT 2023 , Edited by admin on Sat Dec 16 08:35:29 GMT 2023
|
PRIMARY | |||
|
6918419
Created by
admin on Sat Dec 16 08:35:29 GMT 2023 , Edited by admin on Sat Dec 16 08:35:29 GMT 2023
|
PRIMARY | |||
|
214348-10-4
Created by
admin on Sat Dec 16 08:35:29 GMT 2023 , Edited by admin on Sat Dec 16 08:35:29 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |